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Introduction
Transient receptor potential (TRP) channels form a large family 
of cation channels involved in a diverse range of physiological 
functions, and are expressed in almost all cell types (Clapham, 
2003). They play important roles ranging from Ca2+ absorption, 
vasorelaxation, cell death, mechanotransduction, and hearing, 
to the mediation of pH, heat, taste, osmolarity, and pain sensa-
tions. Dysfunctions of TRP channels have been linked to sev-
eral diseases (Nilius et al., 2007). Among members of the TRP 
channel family, the function of TRPM8 could be considered one 
of the most intriguing. Although it was initially cloned from 
the prostate (Tsavaler et al., 2001; Stein et al., 2004) and is ex-
pressed in tissues not affected by ambient temperature fluctua-
tions such as the prostate, testis, and bladder (Tsavaler et al., 
2001; Stein et al., 2004), this channel is mainly known as the 
principal detector of environmental cold (Bautista et al., 2007; 
Colburn et al., 2007; Dhaka et al., 2007).
TRPM8 expression is strongly up-regulated in numerous 
cancers such as that of the prostate, but is dramatically reduced 
during metastasis in androgen-independent prostate cancers 
(Tsavaler et al., 2001; Henshall et al., 2003; Yee et al., 2010). 
This pattern of variation of TRPM8 expression makes it an in-
teresting candidate both as a diagnostic marker for the detection 
of certain cancers and as a prognostic marker in evaluating the 
TRPM8 is a cold sensor that is highly expressed in the prostate as well as in other non-temperature-sensing organs, and is regulated by downstream 
receptor–activated signaling pathways. However, little is 
known about the intracellular proteins necessary for chan-
nel function. Here, we identify two previously unknown 
proteins, which we have named “TRP channel–associated 
factors” (TCAFs), as new TRPM8 partner proteins, and we 
demonstrate that they are necessary for channel function. 
TCAF1 and TCAF2 both bind to the TRPM8 channel and 
promote its trafficking to the cell surface. However, they 
exert opposing effects on TRPM8 gating properties. Func-
tional interaction of TCAF1/TRPM8 also leads to a reduc-
tion in both the speed and directionality of migration of 
prostate cancer cells, which is consistent with an observed 
loss of expression of TCAF1 in metastatic human speci-
mens, whereas TCAF2 promotes migration. The identifica-
tion of TCAFs introduces a novel mechanism for modulation 
of TRPM8 channel activity.
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Results
Identification of the TRP channel–associated 
factors (TCAFs): a family of TRPM8  
partner proteins
To identify TRPM8 regulatory proteins, which have not been 
identified until now, we performed a GST pull-down assay to 
screen lysates of healthy mouse prostates, with the N-terminal 
and C-terminal cytosolic tails of TRPM8 as bait. Fourier trans-
form ion cyclotron resonance mass spectrometry (FTMS) re-
vealed mouse Experimental Autoimmune Prostatitis Antigen 2 
(EAPA2) as a protein interacting with TRPM8. The full list of 
peptides interacting with TRPM8 cytosolic tails is presented in 
Tables S1 and S2. As EAPA2 is not known in humans, we 
searched for highly homologous proteins using National Center 
for Biotechnology Information (NCBI) Blast. Two proteins of 
unknown function, FAM115A, consisting of 921 amino acids 
(NP_055534), and FAM115C, consisting of 845 amino acids 
(NP_001123497), were thus identified and named TCAF1 and 
-2. The alignment of these two proteins with EAPA2 (hereafter 
renamed TCAF3) revealed 51% and 57% of identity, respec-
tively. Once substitutions by similar residues were taken into 
account, the similarity between TCAF3 and TCAF1 or TCAF2 
reached 69% and 66%, respectively (see Fig. 2), which suggests 
that they may have a common origin and belong to the same 
group of genes.
Indeed, a phylogenetic analysis of TCAF1, TCAF2, and 
TCAF3 revealed the presence of a putative gene family. Given 
the sequences available in GenBank, we determined two du-
plication events (Fig. 1 A), supported by both posterior prob-
abilities (PP; Bayesian method) and bootstrap supports (BP; 
maximum likelihood method [ML]). In mammals, up to three 
highly similar genes were found (TCAF1, TCAF2, and TCAF3), 
whereas only one gene copy was seen in fish, amphibians, and 
birds. The mammalian TCAF1 and TCAF2 sequences are phy-
logenetically closer to each other than to the other vertebrate 
sequences. Therefore the first duplication event most likely oc-
curred during mammalian evolution. Given the poor taxon sam-
pling available in the database, it was not possible to precisely 
determine the period of duplication. A second duplication event 
appears to have taken place during rodent evolution to generate 
the TCAF3 gene (Fig. 1 A).
Although mouse TCAF3 is mainly expressed in the pros-
tate, nothing is known about the tissue distribution of the newly 
identified human homologues. We thus examined TCAF1 and 
TCAF2 expression in several human tissue samples using quan-
titative real-time PCR (qPCR). Both transcripts were predomi-
nantly expressed in the prostate (Fig. 1 B), similar to TCAF3 in 
rodents and TRPM8 in humans and rodents.
Both TCAF1 and TCAF2 interact directly 
with the TRPM8 channel
To verify the association of human TCAF1 and TCAF2 proteins 
with TRPM8, we cloned TCAF1 and TCAF2 and studied their 
interaction with TRPM8 by GST pull-down assays. In vitro-
translated [35S]methionine-labeled TCAF1 and TCAF2 strongly 
interacted with the TRPM8 N-terminal tail (GST-M8N) and to 
outcome of these cancers (Zhang and Barritt, 2006). In addi-
tion, it could play a protective role in metastatic prostate cancer 
(Gkika and Prevarskaya, 2011), as recent data show that it 
blocks the migration of prostate cancer cells (Yang et al., 2009; 
Gkika et al., 2010; Zhu et al., 2011). Thus, although TRPM8 is 
considered to be a promising target for pharmaceutical, immuno-
logical, and genetic interventions for the treatment of prostate 
cancer (Zhang and Barritt, 2006), it is first necessary to better 
understand its biological function and the physiological modu-
lators in this organ.
Besides cool temperatures, TRPM8 is also activated by 
several chemical compounds that elicit a sensation of cold, 
of which the best known are menthol, eucalyptol, and the su-
percooling icilin (McKemy et al., 2002; Peier et al., 2002; 
Behrendt et al., 2004; Chuang et al., 2004; Beck et al., 2007; 
Bödding et al., 2007). Chemical agents generally serve as 
positive allosteric modulators. More specifically, because the 
activation of TRPM8 is also voltage dependent, these ago-
nists shift the activation threshold toward more negative po-
tentials, enabling the channel to open at higher than normal 
temperatures, whereas antagonists exert their effect by shift-
ing the threshold of TRPM8 activation toward more positive 
potentials (Brauchi et al., 2004; Voets et al., 2004; Mälkiä 
et al., 2007).
In the absence of the aforementioned physical and 
chemical stimuli, as could be the case in non-temperature-
sensing tissues, TRPM8 could be kept in readiness in a dy-
namic pool of vesicles under the cell surface, awaiting the 
appropriate signal for plasma membrane insertion and chan-
nel activation (Veliz et al., 2010; Latorre et al., 2011). This 
dynamic TRPM8 pool could be activated by intracellular 
factors known to modulate TRPM8 activity, such as second 
messengers generated during the activation of surface-receptor–
coupled signaling pathways (Bavencoffe et al., 2010, 2011; 
Latorre et al., 2011; Yudin and Rohacs, 2012; Zhang et al., 2012; 
Shapovalov et al., 2013a). However, the intracellular elements 
involved in controlling the stabilization of the channel on the 
cell surface and the subsequent amplification of its activity are 
currently unknown.
Several studies show that TRP channels can be regulated 
by partner proteins affecting their trafficking to the plasma 
membrane (Vogel et al., 2007) and/or their channel activity 
(van de Graaf et al., 2003, 2006; Gkika et al., 2004, 2006a,b; 
Sinkins et al., 2004; Chang et al., 2005; Köttgen and Walz, 
2005). Indeed, the regulated translocation of TRP channels 
appears to be a key mechanism for the gating of constitu-
tively active subunits, as well as for enhancing the activity 
of stimulus-gated channels (Shapovalov et al., 2013a). Thus, 
the identification of the molecular components implicated in 
this cellular process is of great importance in understanding 
not only the regulatory mechanisms of TRP channels but also 
their function.
To identify and characterize the molecular determinants 
of TRPM8 regulation, we performed a screening for TRPM8 
partner proteins in the prostate, where the channel is primarily 
expressed. As a result, we have identified a previously uncharac-
terized protein family as a first example of TRPM8 regulators.
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present on the beads and was detected in the precipitated com-
plex (IP) with TCAF1 and TCAF2. No band was detected in 
precipitated complexes from cells that were not transfected with 
TRPM8 or cells immunoblotted for another protein such as actin, 
which indicates the specificity of the interaction (Fig. 3 B). TCAF 
interactions with additional TRP channels were also analyzed 
a lesser extent with the TRPM8 C-terminal tail (GST-M8C), 
whereas no interaction was observed with GST alone (Fig. 3 A). 
This interaction was further confirmed by immunoprecipitation 
experiments in human embryonic kidney (HEK) 293 cells trans-
fected with either HA-tagged TCAF1 or myc-tagged TCAF2, 
with or without his-tagged full-length TRPM8. TRPM8 was 
Figure 1. Bayesian phylogenetic tree of the ver-
tebrate TCAF1/TCAF2/TCAF3 genes and tissue 
expression pattern of the human homologues. 
(A) The maximum likelihood tree was similar but 
for one node: the cow and horse FAM115C se-
quences were sister groups. The phylogenetic re-
construction displays two duplication events, one 
during the early period of mammalian evolution 
and the other during rodent evolution. The scale 
bar represents the number of expected changes 
per site. (B) Analysis of TRPM8, TCAF1, and 
TCAF2 mRNA expression levels by qPCR in sev-
eral human tissues. Values are expressed relative 
to 18S rRNA expression, and further normalized 
to TRPM8 levels in the prostate. Values are pre-
sented as means of three experimental repeats ± 
SEM (error bars; n = 3 for a single experiment).
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revealed significant FRET between TRPM8 and TCAF1 or 
TCAF2 (Fig. 3 F). In control experiments on HEK cells ex-
pressing TRPM8-mTurquoise2 and free SYFP2, no significant 
variation of mTurquoise2 lifetime was detected (Fig. 3 F), and 
calculated EFRET was found to be below the confidence threshold 
of 1%. These observations altogether with biochemical analy-
sis of interaction confirmed in living cells that TCAFs are part-
ners of the TRPM8 channels.
TCAFs exert opposing regulatory effects 
on TRPM8-mediated currents
To assess the functional effect of TCAF1–TCAF2 interactions 
with the TRPM8 channel in human prostate cells, we performed 
a series of patch-clamp experiments. The silencing of native 
TCAFs by siRNAs to TCAF1 or -2 was monitored by RT-PCR 
after 72 h, and specifically abolished TCAF1 or -2 expression 
by coimmunoprecipitation to check whether TCAF is a TRPM8-
exclusive partner. Altogether, these results show that TCAFs 
are potential partner proteins for other TRP channels, such as 
TRPV6 and the short isoform of TRPM2 (Fig. S1, A and B).
Confocal imaging of the cells transfected with HA-tagged 
TCAF1 or myc-tagged TCAF2 and labeled with TRPM8 anti-
bodies confirmed that both TCAFs colocalize with TRPM8 
(Fig. S2, A and B). Direct interaction between the two proteins 
in living cells was confirmed by means of Förster resonance en-
ergy transfer (FRET) using the time-domain fluorescence lifetime 
imaging microscopy (TD FLIM). After the 24-h transfection, 
HEK cells expressing TRPM8-mTurquoise2 and TCAF-SYFP2 
(Fig. 3 C) were analyzed using the time-correlated single 
photon counting (TCSPC) of the donor fluorescence (Fig. 3, 
D and E), and the lifetime of mTurquoise2 was computed on 
a pixel-by-pixel basis (Fig. 3, D and E). Statistical analysis 
Figure 2. Human homologues of TCAF3. Alignment of hFAM115A (TCAF1) and hFAM115C (TCAF2) with the murine EAPA2 (TCAF3) protein. Amino 
acid residues are highlighted in black when present in the three proteins and in gray when they are present in only two of them.
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Figure 3. TCAF1 and TCAF2 interact and colocalize with TRPM8. (A) GST pull-down assay using [35S]methionine-labeled TCAF1 or TCAF2 protein and 
GST or GST fused to the TRPM8 N-terminal tail (GST-M8N) or C-terminal tail (GST-M8C). (B) Cells transfected with HA-tagged TCAF1 or myc-tagged 
TCAF2 with (HEK-M8) or without (HEK) his-tagged full-length TRPM8, and total lysates (TL) were used for immunoprecipitation and subsequent immunoblot 
analysis. Immunoprecipitation of the channel was confirmed by immunoblotting for TRPM8, and the coimmunoprecipitation of TCAF1 or TCAF2 proteins 
was detected using an anti-HA or anti-myc antibody, respectively, on the immunoprecipitated complex (IP). No coimmunoprecipitation was detected in 
control immunoblots for actin. The black lines on the HA-TCAF1 blots indicate the removal of intervening lanes for presentation purposes. (C–F) TCAF1/2-
to-TRPM8 binding was assessed by measuring FRET with TM FLIM in HEK293 cells after a 24-h transfection. The TCSPC approach was chosen to achieve 
a good spatial resolution, which would allow discriminating TRPM8-ER localization. (C) An example of concomitant expression of TRPM8-mTurquoise2 
(cyan) and TCAF1-SYFP2 (yellow). (D and E) Representative FRET-FLIM images for TRPM8-mTurquoise alone and for TRPM8-mTurquoise + TCAF1-SYFP2, 
respectively. Grayscale-coded fluorescence images of the donor of FRET (left images in D and E; fluorescence intensity [FI] is given in arbitrary units [a.u.]) 
were analyzed by the phasor plot method (Phasor) to compute FLIM images (mean) showing the mean lifetime (ns; right images of D and E). The outlines 
define the regions of interest for which mean lifetime of the donor of fluorescence was calculated. Bars, 10 µm. (F) Chart representing the mean lifetime of 
TRPM8-mTurquoise2 alone, coexpressed with the negative control SYFP2, or with TCAF1-SYFP2 or TCAF2-SYFP2. FRET efficiency (EFRET) is shown on the top 
of the chart. Values are presented as means ± SD (error bars). ***, P < 0.001.
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using biotin labeling. Cell-surface biotinylation experiments 
showed that both TCAFs enhanced channel expression in the 
biotinylated fraction when compared with cotransfection with 
at both the mRNA (Fig. 4 A) and protein levels, as seen after 
transfection with vectors expressing tagged proteins (Fig. 4 B). 
We then examined the role of the TCAFs in TRPM8 trafficking 
Figure 4. TCAF1 and TCAF2 proteins have opposing effects on TRPM8 activity. (A) Reverse-transcription PCR showing the specific decrease of TCAF1 
(top) and TCAF2 (bottom) bands after cell transfection with 100 nM of the respective siRNAs. Actin was used to normalize relative expression, and siRNA 
to luciferase was used as a negative silencing control (siLuc). The white line on the TCAF1 gel indicates the removal of intervening lanes for presentation 
purposes. (B) Western blot analysis confirming the siRNA effect on HA-TCAF1– (top) and myc-TCAF2–transfected cells (bottom). Calnexin (Clnx) was used 
as a loading control. (C and D) Cell surface biotinylation analysis of TRPM8-transfected cells cotransfected with the empty vector (CTRL), TCAF1, or TCAF2 
(C), or co-treated with siLuc, siTCAF1, or siTCAF2 (D). TRPM8 expression was analyzed by immunoblotting the plasma membrane fraction (TRPM8PM) or 
total cell lysates (TRPM8TL). Shown is the mean time course of cold- (22°C), icilin- (10 µM), and menthol-activated (500 µM) ITRPM8 in LNCaP cells transiently 
transfected with TRPM8 and treated with siLuc (open circles), siTCAF1 (E), or siTCAF2 (F; closed circles). Values are expressed as means ± SEM (error bars). 
(G) Single traces of menthol-evoked currents recorded in a representative LNCaP cell (out of five different cells per condition) transfected with TRPM8 and 
either an empty vector (ctrl), TCAF1, or TCAF2. Stimulation protocol is presented in the top panel. The corresponding IV relationships are presented in H.
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icilin application was very different between control, TCAF1-
transfected, and TCAF1PI3K-transfected cells: 270.2 ± 52.5 nM, 
1,375.1 ± 174.3 nM, and 692.6 ± 178.3 nM (Fig. 5 C). These 
results show a dramatic halving of TCAF1 function when its 
PI3K homology domain is removed, proving the importance of 
this domain in the mediation of TCAF1’s effect on TRPM8. 
To assess the functional role of the TCAF1 PI3K domain on 
TRPM8 activity, the effect of pretreatment with 1 µM wortman-
nin was tested on cells transfected with either wild-type TCAF1 
or TCAF1PI3K. While TCAF1-transfected cells revealed strong 
sensitivity to wortmannin, the TRPM8-mediated current in 
TCAF1PI3K-transfected cells was wortmannin insensitive (Fig. 5, 
D and E). Currents elicited by cold, icilin, and menthol were, re-
spectively, 435.2 ± 76.8, 254.7 ± 42.7, and 275.3 ± 52.2 pA/pF in 
control (n = 4), and 78.5 ± 22.7, 76.9 ± 16.2, and 57.1 ± 11.8 
pA/pF in wortmannin-treated TCAF1-transfected cells (n = 5); 
and 142.7 ± 25.9, 172.7 ± 29.9, and 130 ± 23.4 pA/pF in control 
(n = 4), and 188.7 ± 70.8, 191.6 ± 80.1, and 135.6 ± 34.5 pA/pF 
in wortmannin-treated TCAF1PI3K-transfected cells (n = 6).
We then examined the effect of this domain on TRPM8 
trafficking to the plasma membrane. Cotransfection of TRPM8 
with TCAF1 or TCAF1PI3K followed by cell-surface biotinyl-
ation showed that both TCAF1 and its truncated form enhanced 
channel expression in the biotinylated fraction compared with 
cotransfection with the empty vector (Fig. 5 F).
TCAF1 and TCAF2 exert opposing 
regulatory effects on endogenous  
TRPM8 activity
To analyze whether TCAF1 and TCAF2 are involved in the regu-
lation of native TRPM8, we examined how the level of TCAF1 
or TCAF2 expression would affect menthol-induced [Ca2+]i 
responses in LNCaP cells, which naturally express TRPM8 
(Valero et al., 2011, 2012). We first confirmed TRPM8 expression 
and activity in these cells by using siRNAs targeting the chan-
nel (Fig. S2, E and F). Next, we compared [Ca2+]i responses to 
200 µM menthol in fluo-4–loaded control LNCaP cells, LNCaP 
cells overexpressing either TCAF1 or TCAF2, and LNCaP cells 
pretreated with either control siRNA (siLuc), TCAF1 siRNA, or 
TCAF2 siRNA (Fig. 6). The siRNA experiments were also per-
formed in human epithelial prostate cells, Ep156T (Fig. S3). Our 
results revealed that both the amplitude of the response and its 
temporal profile depended on the level of TCAF1 and TCAF2 
expression. In control (Fig. 6 A) and TCAF1-overexpressing 
(Fig. 6 B) LNCaP cells, as well as in LNCaP (Fig. 6 E) and 
Ep156T (Fig. S3 A) cells pretreated with siLuc or siTCAF2 
(Fig. 6 G and Fig. S3 C), menthol triggered a high-amplitude 
[Ca2+]i transient. The magnitude of this oscillatory response was 
significantly reduced in cells overexpressing TCAF2 (Fig. 6 C) 
and was increased after pretreatment with siTCAF2 (Fig. 6 G 
and Fig. S3 C). In LNCaP cells overexpressing TCAF1, an initial 
phase of the menthol-induced response was followed by several 
long-period [Ca2+]i oscillations of smaller amplitude (Fig. 6 B), 
whereas pretreatment with siTCAF1 virtually abolished all the 
response in both LNCaP (Fig. 6 F) and Ep156T (Fig. S3 B). As 
the temporal pattern of the [Ca2+]i response to TRPM8 activa-
tion is complex, to quantify the effects of TCAF overexpression 
an empty vector (Fig. 4 C), whereas siRNA to TCAF1 signifi-
cantly decreased channel abundance on the plasma membrane 
compared with control siRNAs (siLuc; Fig. 4 D).
In terms of channel activity, TCAF1 silencing in these 
cells at 37°C induced a decrease in basal TRPM8 activity from 
88.2 ± 15.5 to 58.9 ± 5.3 pA/pF (Fig. 4 E). A similar inhibitory 
effect was observed on ITRPM8 currents evoked by cold, icilin, and 
menthol, which decreased from 158.1 ± 73.7, 111.6 ± 38.5, and 
54.9 ± 16.4 pA/pF in control cells (n = 12) to 22.8 ± 13.3, 40.8 ± 
10.1, and 32.3 ± 11.1 pA/pF, respectively, in cells transfected 
with TCAF1 siRNA (siTCAF1; n = 8). In contrast, TCAF2 si-
lencing led to an increase in basal ITRPM8 amplitude from 88.2 ± 
15.5 to 187.4 ± 47.9 pA/pF (Fig. 4 F), whereas responses to 
cold, icilin, and menthol were increased from 158.1 ± 73.7, 
111.6 ± 38.5, and 54.9 ± 16.4 pA/pF in control cells (n = 12) 
to 341.3 ± 131.9, 164.2 ± 42.3, and 115.7 ± 62.2 pA/pF, re-
spectively, in cells treated with TCAF2 siRNA (siTCAF2; 
n = 4). A histogram summarizing these results at both +100 and 
100 mV is presented in Fig. S2 C, and shows similar effects 
of partner proteins silencing at both potentials. The overexpres-
sion of TCAF1 and TCAF2 had an opposite effect to that of 
the siRNAs, confirming the activating role of TCAF1 and the 
inhibitory role of TCAF2 on TRPM8 activity (n = 5; Fig. 4, 
G and H; and Fig. S2 D). These results clearly show that TCAF1 
and -2 can modulate TRPM8 basal activity, therefore suggest-
ing a potential role of this interaction in controlling calcium ho-
meostasis. Moreover, TCAF1 and -2 effects on TRPM8 activity 
were equally observed for all tested potentials, thus precluding 
the existence of a voltage-dependent component to these inter-
actions (Fig. 4 H).
The C-terminal tail of TCAF1 plays a 
critical role in TRPM8 regulation
TCAF1 and -2 both bind to TRPM8 and augment its targeting to 
the plasma membrane, while having different effects on channel 
activity. We therefore searched the protein sequences of TCAF1 
and TCAF2 for domains that could explain this disparity. A low 
homology with the PI3K domain was predicted using the Con-
served Domains software tool from NCBI on the C-terminal 
tail of TCAF1. Interestingly this domain is missing from the 
TCAF2 sequence, as shown in the diagram in Fig. 5 B.
To validate this putative PI3K domain in TCAF1 and assess 
its role in TRPM8 regulation, we first used a pharmacological 
approach, namely, a commonly used PI3K inhibitor wortmannin, 
at 1 µM. As shown in Fig. 5 A, pretreatment with wortmannin re-
sulted in a massive decrease in ITRPM8 amplitude under resting 
conditions as well as during exposure to cold, icilin, or menthol.
Second, we generated a truncated version of TCAF1, 
which lacks the C-terminal tail that contains the PI3K homol-
ogy domain (TCAF1PI3K) and resembles TCAF2. The direct 
interaction of TCAF1PI3K with TRPM8 cytosolic tails was ex-
amined by GST pull-down. In vitro-translated [35S]methionine-
labeled TCAF1 and TCAF1PI3K both strongly interacted with 
the TRPM8 N-terminal tail (GST-M8N) and to a lesser extent 
with the TRPM8 C-terminal tail (GST-M8C; Fig. 5 B). The 
functionality of TCAF1PI3K was then assessed by Ca2+ imaging 
and patch-clamp experiments. Strikingly, the Ca2+ response to 
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pretreated with siLuc with that pretreated with either siTCAF1 
or siTCAF2. Menthol-induced [Ca2+]i responses were directly 
correlated with changes in TCAF1 expression but inversely 
correlated with changes in TCAF2 expression, which indicates 
and siRNAs, we compared the fluo-4 signal during the first 18 
min after menthol application in control LNCaP cells with that 
in LNCaP cells overexpressing TCAF1 or TCAF2 (Fig. 6 D), 
and the signal in LNCaP (Fig. 6 H) and Ep156T cells (Fig. S3 D) 
Figure 5. TCAF1 exhibits a PI3K homology domain that is critical for the TCAF1 modulation of TRPM8 activity. (A) Mean time course of cold- (22°C), icilin- 
(10 µM), and menthol-activated (500 µM) ITRPM8 in LNCaP cells pretreated (closed circles) or not (ctrl, open circles) for 15 min with 1 µM wortmannin. For 
pretreated cells, experiments were performed in the continuous presence of wortmannin at the same concentration. Currents were monitored at +100 mV, 
and results are presented as means ± SEM (error bars). (B) GST pull-down assay between [35S]methionine-labeled TCAF1 or TCAF1PI3K protein and GST 
or GST fused to the TRPM8 N-terminal tail (GST-M8N) or C-terminal tail (GST-M8C). A schematic representation of TCAF1 and TCAF2 protein sequences 
and the putative PI3K site is shown. (C) Time course of mean intracellular Ca2+ concentration in LNCaP cells transfected with TRPM8 and an empty vector 
(ctrl, open circles), wild-type TCAF1 (TCAF1, black closed circles), or a truncated TCAF1 lacking the PI3K domain (TCAF1PI3K, gray closed circles). Cells 
were loaded with Fura 2-AM, exposed to 10 µM icilin, and variations in [Ca2+]i were monitored using an imaging system. Results are presented as means ± 
SEM (error bars). (inset) Histogram summarizing calcium imaging results (**, P < 0.01; ***, P < 0.001). (D and E) Histograms presenting mean cold- 
(22°C), icilin- (10 µM), and menthol-activated (500 µM) ITRPM8 in LNCaP cells transiently transfected with TRPM8 and wild-type TCAF1 (D) or TCAF1PI3K 
(E), and then treated (black columns) or not (white columns) with 1 µM wortmannin. Results at +100 and 100 mV are presented as means ± SEM (error 
bars; **, P < 0.01). (F) Cell surface biotinylation analysis of cells cotransfected with TRPM8 and the empty vector (CTRL), TCAF1, or TCAF1PI3K. TRPM8 
expression was analyzed by immunoblotting the plasma membrane fraction (TRPM8PM) or total cell lysates (TRPM8TL).
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Figure 6. The menthol-induced response of endogenous TRPM8 is modulated by TCAF1 and TCAF2. (A–G) Changes of [Ca2+]i in response to the activation 
of TRPM8 with 200 µM menthol were monitored using an x-y time-series imaging of fluo-4 fluorescence in control LNCaP cells (A), LNCaP cells overex-
pressing TCAF1 (B) or TCAF2 (C), and LNCaP cells pretreated with siLuc (E), siTCAF1 (F), or siTCAF2 (G). Images were acquired at 0.6 Hz from confocal 
optical slices <4 µm. The fluorescence intensity (F) was normalized to the averaged fluorescence intensity before menthol application (F0). Relative changes 
in fluorescence intensity (F/F0), averaged within each of 10 cells denoted by the numbers on the images (left), are plotted over time. Menthol application 
is depicted on the 3D plots by vertical cyan bars. The galleries below the plots demonstrate the images of fluo-4 fluorescence captured at times indicated 
above the images. Bar diagram plots compare masses of the fluo-4 signal, ( ),∫ ∆F F0 during the first 18 min after menthol application (D) in LNCaP cells 
overexpressing TCAF1 (n = 48) or TCAF2 (n = 51) versus control LNCaP cells (n = 62), and in LNCaP cells (H) pretreated with siTCAF1 (n = 56) or siTCAF2 
(n = 42) versus LNCaP cells pretreated with siLuc (n = 52). Values are expressed as means ± SEM (error bars). ***, P < 0.001; **, P < 0.01.
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states in the 4c2o model, emphasizing the significance of these 
additional kinetic states in activity of TRPM8. In other words, 
the binding of TCAF1 to the TRPM8 channel introduces new 
kinetic states that are necessary for a satisfactory description 
of TRPM8 gating, which implies a direct binding of TCAF1 
to TRPM8.
TCAF1 but not TCAF2 shows expression 
patterns similar to TRPM8 during 
carcinogenesis, and slows down  
cell migration
Given the fact that TRPM8 is a marker for prostate cancer, we 
investigated by qPCR whether the expression of its interacting 
proteins, TCAF1 and TCAF2, was also associated with prostate 
cancer development. We initially studied TRPM8, TCAF1, and 
TCAF2 expression in healthy and cancerous human prostate re-
section samples. Patients were included in the study when both 
tumoral and nontumoral (healthy) tissue could be obtained from 
the same individual. TRPM8 and TCAF1 expression were sig-
nificantly increased in cancerous samples when compared with 
healthy ones (10 and 5 times, respectively; n = 7–10 for each 
condition, P < 0.05), whereas no difference was observed for 
the TCAF2 transcript (Fig. 8 A).
We then assessed the variation in expression of these tran-
scripts between localized prostate cancer and metastasis to the 
bone marrow of patients previously subjected to androgen abla-
tion therapy. qPCR analysis showed a clear decrease in both 
TRPM8 and TCAF1 expression in metastatic samples in com-
parison with localized prostate cancer (n = 7–10 for each con-
dition, P < 0.01). TCAF2 expression remained unchanged, as 
before (Fig. 8 B).
To verify that the similar expression patterns of TRPM8 
and TCAF1 during carcinogenesis were also important at the 
functional level, we investigated the role of TCAF1 in prostate 
cell migration by performing time-lapse microscopy experi-
ments on either PC3 or LNCaP prostate cancer cells (Fig. 9).
TRPM8 overexpression significantly decreases the cell 
migration speed, and this effect is exacerbated in the presence 
of icilin stimulation (Fig. 9, A and B), in accordance with our 
previous results on wound healing and transwell assays (Gkika 
et al., 2010). Moreover, TCAF1 overexpression significantly 
decreased the cell migration speed (Fig. 9, A and B) even in the 
absence of TRPM8 (Fig. 9 B). However, when overexpressed 
together with TRPM8, we observed a further significant de-
crease in the speed, which indicates that the TCAF1 effect is, at 
least partially, mediated by TRPM8 (Fig. 9, B and C). To test 
whether the inhibition of cell migration was due to the PI3K 
domain of TCAF1, we performed cell migration assay in cells 
overexpressing TCAF1PI3K (Fig. 9, A and C). We indeed ob-
served a significant increase in the migration speed of cells 
transfected with TCAF1PI3K versus TCAF1-transfected cells 
(Fig. 9, A and C); this effect is further increased in the presence 
of TRPM8 (Fig. 9 C). These results are in agreement with mod-
ulation of TRPM8-mediated current by PI3K domain of TCAF1 
(Fig. 5, D and E). Although TCAF2 inhibits the migration speed 
in the absence of TRPM8, it significantly increases the speed 
when TRPM8 is expressed (Fig. 9 C).
that TRPM8 channel opening is facilitated by TCAF1 and sup-
pressed by TCAF2.
TCAF1 binding introduces new kinetic 
states to TRPM8 single channel activity
Next, we checked for any potential effect of TCAF1/TCAF2 on 
TRPM8 activity at the single channel level. These experiments 
were performed in HEK 293 cells expressing TRPM8 under 
the control of a tetracycline-inducible promoter (HEK-293M8i; 
Thebault et al., 2005) in order to limit the contamination of 
our recordings by the activity of other channels. Control HEK-
293M8i cells as well as cells transfected with TCAF1 or TCAF2 
plasmids were subjected to a short tetracycline induction as de-
scribed. Then, TRPM8 activity was measured in cell-attached 
configuration by first recording activity at room temperature 
followed by the application of 100 µM menthol (see Fig. S4 
for sample traces). While comparing activity in control and 
TCAF1-transfected cells, two types of activity became appar-
ent (Fig. 7 A). The first type, characterized by short, separate 
openings, was most common to control cells (19 control and 4 
TCAF1-bound traces), whereas the second type exhibited the 
clustering of openings without any apparent increase in opening 
duration and was prevalent in TCAF1-transfected cells (5 con-
trol and 29 TCAF1-bound traces). In contrast, cells transfected 
with TCAF2 and induced according to an identical protocol ex-
hibited virtually no TRPM8 activity (only 4 out of 31 traces 
exhibited TRPM8 opening), leading us to conclude that TCAF2 
silences the TRPM8 channel (unpublished data).
To further study how TCAF1 binding modifies TRPM8 
gating properties, the acquired traces were scrutinized for the 
appearance of multiple conductance levels, and those containing 
single-channel activity (four control and three TCAF1-bound) 
were individually analyzed, as described previously (Qin and 
Li, 2004; Fernández et al., 2011). Fig. 7 (B–D) summarizes 
dwell-time distributions, kinetic rates, and energy landscapes 
representing typical control and TCAF1-bound TRPM8 activity 
at room temperature and after stimulation by menthol. Interest-
ingly, stimulation of TRPM8 activity by menthol only led to 
changes in the energy of the closed states, correspondingly in-
creasing the frequency of channel openings while preserving the 
overall model. However, the effect of TCAF1 was qualitatively 
different. Although the analysis of control activity showed that 
the gating of TRPM8 alone could be reliably described by a rela-
tively simple model, containing three closed and one open kinetic 
states (the 3c1o model; two upper panels on Fig. 7, C and D), 
this was not the case for the TCAF1-bound activity, suitable 
representation of which required a more complex model with 
four closed and two open states (the 4c2o model; two lower 
panels on Fig. 7, C and D). Fig. S5 compares the fits of the 
TRPM8 activity by the 4c2o and 3c1o kinetic models. Analy-
sis of the activity of TRPM8 alone (Fig. S5, A and C) shows 
that both models yield identical log likelihood with additional 
states of the 4c2o model exhibiting virtually zero occupancy, 
which validates the simpler 3c1o model. On the contrary, 
analysis of the activity of TRPM8 interacting with TCAF1 
(Fig. S5, B and D) shows significantly larger changes in log 
likelihood as well as a nontrivial occupancy of the additional 
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acting on the directional persistence index (Fig. 9 E) and not on 
the speed (Fig. 9 D). The effect on directional migration index 
of siTCAF1 is exacerbated in the presence of TRPM8 (Fig. 9 E). 
Finally, we studied the effect of native TCAFs on cell 
migration with an siRNA approach. As expected, TCAF1 down-
regulation increases migration, which interestingly occurs by 
Figure 7. TCAF1 interaction with TRPM8 introduces new kinetic states. (A) Representative trace fragments of control and TCAF1-bound TRPM8 activity 
stimulated by cold (T = 20°C, controlled by room thermostat) or cold + 100 µM menthol, as indicated. (B) Representative distributions of closed (left) 
and open (Chetrite et al., 2000) dwell times in the traces of control and TCAF1-bound TRPM8 activity stimulated as indicated. The histogram shows the 
distribution of dwell times. The thick continuous line represents the cumulative best fit corresponding to the kinetic model used (C) and broken lines rep-
resent individual components of the fit. (C) Kinetic models providing the best fit to the control and TCAF1-bound TRPM8 activity. The area of each circle 
is proportional to the log of total time spent the corresponding state. Kinetic rates are indicated as numbers associated with the corresponding arrows. 
(D) Energy landscapes calculated from the corresponding kinetic models. Arrows point to significantly shifted energies in corresponding states caused by 
menthol stimulation. Note that contrary to the effects of different modes of TRPM8 stimulation (shifts in state energies), the interaction with TCAF1 leads to 
the appearance of new kinetic states.
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as well as electrophysiological measurements that the TCAFs 
interact directly with TRPM8, exerting opposing effects on 
channel activity. We have subsequently unraveled the molecular 
mechanism of TCAF action on TRPM8 activity using directed 
mutagenesis, biochemical assays, and single-channel analysis, 
demonstrating: (1) a domain responsible for their distinct channel 
regulation activities, (2) the effect of the TCAFs on channel plasma 
membrane trafficking, and (3) the qualitative effect on TRPM8 
activity via the introduction of new kinetic states during gating. 
At the cellular level, the functional TCAF1–TRPM8 interaction 
leads to the inhibition of cell speed, which is also supported by 
the loss of expression of these proteins in human metastatic speci-
mens. Indeed these two proteins are mainly expressed in the pros-
tate, as demonstrated by the qPCR screening of human tissues.
Addressing the molecular mechanisms responsible for the 
regulation of TRPM8 activity and expression by the TCAFs, we 
have shown that the TCAFs interact mainly with the TRPM8 
N-terminal tail. Our data imply that both proteins are critical for 
TRPM8 function because their silencing prevents the channel’s 
insertion into the plasma membrane. GST pull-down experi-
ments with in vitro translated TCAFs strongly point to the di-
rect binding of TCAFs to TRPM8, which is further supported 
by the introduction of new kinetic states to TRPM8 single-channel 
kinetics in the presence of the TCAF1 protein, whereas TCAF2 
completely silences the channel while retaining it in plasma 
membrane. Interestingly, this situation closely resembles the 
role that  subunits play in regulating T-type calcium channels 
through the direct interaction of involved proteins (Gerster 
et al., 1999). To understand the opposing modulatory effects of 
TCAF1 and TCAF2, one has to look at sequence differences 
between the proteins, such as the loss of the C-terminal extrem-
ity in TCAF2. However, the removal of this region in TCAF1 
(TCAF1PI3K) did not completely mimic the behavior of TCAF2, 
and although TCAF1PI3K overexpression indeed leads to a de-
crease in ITRPM8 amplitude when compared with TCAF1, the ex-
tent of this decrease is significantly lower than that observed 
with TCAF2 overexpression. The presence in this region of a 
PI3K homology domain coupled with our observation that (1) a 
PI3K inhibitor (wortmannin) inhibits TRPM8 activity and that 
(2) this sensitivity to wortmannin is abolished in cells overex-
pressing TCAF1PI3K strongly suggest that the regulatory role of 
the TCAFs also involves phosphorylation. In this model, both 
TCAF1 and TCAF2 proteins bind to TRPM8, affecting its ex-
pression on the plasma membrane. The presence of a functional 
PI3K homology domain, however, is required to make the chan-
nel fully active. Moreover this domain is also critical for cell 
motility because TCAF1PI3K transfection partially reverts the 
inhibitory effect exerted by TCAF1. However it should be noted 
that because the TCAF1PI3K mutant implies the deletion of 
TCAF1 C terminus, the loss of function may not be due only to 
the disruption of the PI3K-specific enzymatic activity. More ex-
periments are thus needed to characterize the respective roles of 
TCAF1 functional enzymatic domain and C terminus.
Our phylogenetic analysis revealed that human TCAF1 
and -2 are homologues of rodent TCAF3 (EAPA2) and that 
these three proteins form a new protein family originating from 
two duplication events. TCAF3 was identified in 2006 by mass 
However, we clearly show that TCAF2 has a strong promigra-
tory effect, which is more pronounced during TRPM8 activa-
tion, as observed by the strong inhibition of cell migration in the 
presence of siTCAF2 and icilin (Fig. 9 F).
Discussion
Ion channels are known to have protein partners that regulate 
channel localization or gating, leading to important physiologi-
cal consequences. In some of the better known cases, such as 
the T-type calcium channels, these proteins are even acknowl-
edged as subunits of the involved ion channel (Gerster et al., 
1999). Here, we present a family of proteins, the TCAFs, which 
regulate the trafficking as well as gating of TRPM8, the ion 
channel that is known to serve as a thermal sensor in peripheral 
neurons and to play an important role in prostate cancer. We 
have demonstrated by means of cellular and molecular biology 
Figure 8. TCAF expression profile in prostate cancer. (A and B) Analysis 
of TRPM8, TCAF1, and TCAF2 mRNA expression levels by qPCR in healthy 
and cancerous human prostate samples (A), as well as in localized and 
metastatic human prostate cancer specimens (B). Values are calculated 
relative to 18S rRNA expression and presented as means ± SEM (error 
bars; n = 7–10; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
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different regulatory effects on TRPM8. In this regard, the relative 
abundance of TCAFs and their competition in binding TRPM8 
seems to be critical in the physiological regulation of the chan-
nel activity. This is further supported by the differences in TCAF’s 
effect on single channel activity (the addition of one open state 
for TCAF1), while their binding to the channel is similar, as 
shown in the GST pull-down and coimmunoprecipitation assays. 
Moreover, the expression of TCAF1 is universally and closely 
spectrometric analysis as a new prostate-specific protein regu-
lated by androgens in mice (Fujimoto et al., 2006). At the time, 
the function of TCAF3 was unknown and no homologues had 
been identified in humans. Our discovery of the TCAF–TRPM8 
interaction allows us to assign a role to this important family of 
proteins, often coexpressed with the TRPM8 channel. Interest-
ingly, although TCAF1 and -2 share a common phylogenetic ori-
gin and exhibit a high degree of homology, they exert completely 
Figure 9. TCAF functional role in prostate 
cancer cell migration. (A) Representative mi-
gration plots of control (top left) and TRPM8-
overexpressing cells (top right) or TRPM8 
cotransfected with wild-type TCAF1 (bottom 
left) or truncated TCAF1 lacking the PI3K 
domain (TCAF1PI3K, bottom right). Each line 
represents the migration of one cell within 
a 10-h period. The data shown are from a 
single representative experiment out of three 
repeats. For the experiment shown: CNTRL 
n = 28, TRPM8 n = 58, TRPM8/TCAF1 n = 
69, TRPM8/TCAF1PI3K n = 98. (B and C) 
Bar graphs showing the quantification of cell 
speed in control nontransfected prostate can-
cer cells (CNTRL), TRPM8-overexpressing 
cells (TRPM8), TCAF1-overexpressing cells 
(TCAF1), TRPM8- and TCAF1-overexpressing 
cells (TRPM8/TCAF1), and TRPM8 and TCAF1 
lacking the PI3K domain (TCAF1PI3K) in the 
presence or absence of 10 µM icilin. (D–F) Bar 
graphs showing the quantification of cell speed 
(D) and the migratory persistence index (E, cal-
culated as indicated in the online materials) in 
control cells and TRPM8-overexpressing cells 
in which TCAF1 or TCAF2 are down-regulated 
(TRPM8/siTCAF1), in the presence or absence 
of 10 µM icilin (F). Each graph represents 
the quantification of pooled independent ex-
periments (at least three experiments for each 
experimental condition). For each experiment, 
at least 60 cells were followed per condition 
(*, P < 0.05 relative to CNTRL; § relative to 
TRPM8). Data are expressed as means ± SEM 
(error bars).
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alignment. A data matrix containing 2,790 bp was further used for phylo-
genetic analyses. Any sequence shorter than half the final matrix length was 
removed, yielding a total of 21 sequences (NM_203396, NM_001009534, 
 BC000609, XM_519454, NM_001132598, NM_029930, XM_342675, 
XM_002711950, XM_843498, NM_001099054, NM_001130025, XM_ 
519453, XM_539847, NM_001101924, XM_001490518, NM_
146174, XM_001057103, XM_002190925, NM_001094696, 
NM_001089327, and NM_001089327). Phylogenetic reconstructions 
were performed with the maximum likelihood method (ML) using PhyML 
3.0 (Guindon and Gascuel, 2003), and by Bayesian analyses using 
MrBAYES, version 3.1.2 (Huelsenbeck and Ronquist, 2001). The best-fit 
model under the ML criterion was selected from the “Akaike Criterion” out-
put of MODELTEST, version 3.7 (Posada and Crandall, 1998). For the ML 
analyses, node stability was estimated by 100 nonparametric bootstrap repli-
cates (Felsenstein, 1988). For the Bayesian analyses, the dataset was di-
vided into three partitions according to codon positions. MODELTEST 
version 3.7 was used to calculate the best-fit model of sequence evolution 
for each partition. Two runs of four Markov chains were calculated simulta-
neously for 4,000,000 generations with equal initial probabilities for all 
trees and starting with a random tree. Tree sampling frequency was each 
100 generations and the consensus tree with posterior probabilities was 
calculated after removal of the first 25% of the total number of trees gener-
ated, corresponding to 10,000 trees. The mean standard deviation of split 
frequencies between the two independent runs was <0.01.
qPCR
qPCR of mRNA transcripts was done using MESA GREEN qPCR MasterMix 
Plus for the SYBR Assay (Eurogentec) on the CFX96 Real-Time PCR Detec-
tion System (Bio-Rad Laboratories) and the LightCycler System (Roche). The 
sequences of the primers were: for TRPM8, 5-CGGTCATCTACGAGCC-
CTAC-3 and 5-CACACACAGTGGCTTGGACT-3; for TCAF1, 5-TTG-
CCCACAGAAAATGTTGA-3 and 5-CAGATAGGCCAGGCTGGTAG-3; 
for TCAF2, 5-ACCACGAGAATGGGAACTTG-3 and 5-GAGCCTGTG-
CAGGGATATGT-3; for 18S rRNA, 5-CAGCTTCCGGGAAACCAAA-
GTC-3 and 5-AATTAAGCCGCAGGCTCCACTC-3; for actin, 5-TTG-
CTGATCCACATCTGCTG-3 and 5-GACAGGATGCAGAAGGAGAT-3. 
-Actin mRNA and 18S rRNA were used as endogenous controls to nor-
malize variations in RNA extraction, the degree of RNA degradation, and 
the variability of reverse transcription efficiency. To quantify the results, 
we used the comparative threshold cycle method described by Livak and 
Schmittgen (2001).
For regular PCR, the following primers were used: for actin, 5-
CAGAGCAAGAGAGGCATCCT-3 and 5-GTTGAAGGTCTCAAAC-
ATGATC-3; for TCAF1, 5-ATGGCGACTCCCTCTGCTGC-3, 5-CCC-
AATCCCAGGCTTGTCCT-3, 5-CTACTGCTGCAAGGCGTACA-3, and 
5-CCAGACCCTCGTAGCATCTT-3.
Cancer tissue sampling
Prostate tissue samples (prostate adenocarcinoma) were obtained from 15 
patients with a mean age of 62.4 yr (ranging from 51 to 70) who under-
went radical prostatectomy between January 2004 and June 2008 at the 
Department of Urology at the Lyon-Sud Hospital Centre. All fragments were 
snap-frozen and stored in liquid nitrogen until analysis. To ascertain 
whether the tissue was malignant or nontumoral and to confirm the Glea-
son score, a histological analysis of frozen sections of each sample was 
performed by the same pathologist before RNA extraction. Fragments fully 
made up of tumoral tissue were selected and classified as “tumoral,” 
whereas samples containing no tumoral tissue were selected and classified 
as “nontumoral.” Fragments with a mix of normal and tumoral tissue were 
excluded from the study. Patients were included in the study when both a 
“tumoral” sample and a “nontumoral” sample could be obtained from the 
same individual.
In addition, we used nine samples from both localized and meta-
static prostate cancer obtained after informed consent from patients with 
localized (T2a-b) PCa for whom a prostatectomy has been scheduled, and 
patients with metastatic PCa (M1), which progressed on androgen abla-
tion therapy, were included in a clinical research program (Protocol ID 
2897) sponsored by the Hôpitaux Universitaires de Strasbourg. A total 
volume of 3 ml of bone marrow were aspirated at a scintigraphic-indicated 
metastatic site. Microscopic observations were made from an aliquot of 
each bone marrow aspirate to confirm or rule out the presence of meta-
static PCa cells. Total RNAs were extracted from small pieces of localized 
tumor by the use of the RNeasy midi kit (QIAGEN) and from bone marrow 
aspirates by the use of the Qiamp RNA blood kit (QIAGEN) according to 
the manufacturer’s instructions.
linked to TRPM8 expression, whereas the expression of TCAF2 
is mostly independent and does not exhibit large variations. Al-
though coupling with TCAF2 completely silences TRPM8 ac-
tivity, its physiological role is not clear in nonoverexpressing 
systems. We speculate that this might be due to the loss of the 
C-terminal domain in the human TCAF2. This result may be 
different for other mammalian TCAF2s, as this domain is still 
present in the genes we used for the phylogenetic analysis.
The highest expression of TRPM8 is in the prostate, where it 
is suggested to play a role in carcinogenesis (Thebault et al., 2005; 
Bidaux et al., 2007; Sabnis et al., 2008; Wondergem et al., 2008). 
Prostate carcinogenesis is commonly associated with major altera-
tions in TRPM8 expression and its signaling pathway (Bavencoffe 
et al., 2011; Gkika and Prevarskaya, 2011; Prevarskaya et al., 
2011; Shapovalov et al., 2013b). In support of this hypothesis, 
our data reveal that TRPM8 and TCAF1 proteins show similar 
expression patterns in all tissues studied. Specifically, TCAF1 
expression levels increase in cancerous human prostate tissue 
and drop in metastatic tissue, mirroring TRPM8 levels. How-
ever, the expression levels of TCAF2 remain unchanged, which 
suggests the differential regulation of the two transcripts and 
reflects their divergence at the functional level. These observa-
tions mark TCAF1 as a good candidate for inclusion in the list 
of well-known prognostic markers such as TRPM8, prostein, 
and the prostate-specific antigen (PSA), which are also deregu-
lated in localized primary prostate cancer, whereas their overex-
pression is lost again at advanced tumor stages (Schmidt et al., 
2006). Moreover, the increased TRPM8 activity and expression 
linked to the presence of TCAF1 also affects cell migration, as 
shown by our time lapse video microscopy experiments, and which 
is in accordance with previous studies linking the overactivity of 
TRPM8 protein with the reduced motility of prostate cancer cells 
(Gkika et al., 2010). More specifically, TCAF1 exerts an antimi-
gratory effect on prostate cancer cells by acting on the cell migra-
tion persistence, thus confirming the role of TCAF1 as a TRPM8 
activator. However, the complexity of interactions described and 
the results of our initial GST pull-down, coimmunoprecipitations, 
and migration assays suggest that TCAFs are partner proteins for 
other ion channels, such as TRPV6 and the short isoform of 
TRPM2, which clearly indicates the need for further studies.
Finally, although TCAFs are strongly expressed in the pros-
tate, we show that they are also detected in other tissues, includ-
ing the brain. It is therefore possible that TCAFs are not merely 
limited to the role of partner proteins in prostate cells, but are 
also required and can be therapeutically targeted in other tissues 
for the stabilization of the expression and modulation of the ac-
tivity of this channel. For example, TCAFs and their associated 
molecular pathways could be targets for pain management, ac-
cording to several recent studies on TRPM8 and allodynia (Chung 
et al., 2011; Descoeur et al., 2011; Su et al., 2011; Kawashiri 
et al., 2012; Shapovalov et al., 2013a).
Materials and methods
Phylogenetic analysis
For the three genes TCAF1, TCAF2, and TCAF3, homologous sequences 
were downloaded from GenBank. Sequences were aligned using Seaview 
version 4.2.6 (Gouy et al., 2010) and manually adjusted for amino acid 
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transformed with the pGEX6P-2 constructs and cultured in 2XTY medium 
containing ampicillin (100 µg/ml) at 37°C until the OD reached 0.4–0.6. 
IPTG was then added to a final concentration of 0.2 mM to induce expres-
sion at 30°C for 4 h. The bacteria were pelleted and resuspended in STE 
buffer I (10 mM Tris-HCl,150 mM NaCl, and 1 mM EDTA, pH 8.0), and 
the cells were broken by lysozyme (10 mg/ml) incubation. After adequate 
sonication, the broken cells were pelleted at 13,000 rpm for 30 min at 
4°C, and the supernatant was collected for purification. Because pGEX-6P-2 
contains the coding region for GST, we used glutathione Sepharose 4B 
beads (GE Healthcare) to purify the TRPM8 N and C tails.
TCAF1, TCAF2, and TCAF1PI3K proteins were labeled with [35S] 
methionine using a reticulocyte lysate system as per the manufacturer’s in-
structions (Promega), added to purified GST fusion proteins, and immobi-
lized on glutathione Sepharose 4B beads in PBS containing 1% vol/vol 
Triton X-100. After a 2-h incubation at room temperature, the beads were 
washed extensively and bound proteins were eluted with SDS-PAGE load-
ing buffer, separated on 10% wt/vol SDS-PAGE gels, and visualized 
by autoradiography.
Preparation of prostate lysates, pull-down assay, and Fourier transform 
mass spectrometric analysis
The prostate was isolated from two 12-wk-old C57BL/6 male mice, which 
were sacrificed under 1.5% vol/vol isoflurane anesthesia (Nicholas Pira-
mal Limited). The animal ethics board of the Radboud University Nijmegen 
approved all animal experimental procedures.
The two prostates were homogenized in homogenization buffer A 
(HbA; 20 mmol/liter Tris/HCl, pH 7.4, 5 mmol/liter MgCl, 5 mmol/liter 
NaH2PO4, 1 mmol/liter EDTA, 80 mmol/liter sucrose, 1 mmol/liter PMSF, 
and 5 g/ml leupeptin and pepstatin). The protein concentration of the ho-
mogenates was determined with the Bio-Rad protein assay (Bio-Rad Labo-
ratories). The lysates were subjected to GST pull-down with theTRPM8 N- and 
C-terminal tail GST fusion proteins while GST alone and another TRP chan-
nel (TRPV6 C-tail) were used as binding controls (as described in the GST 
pull-down section).
GST-precipitated proteins were subjected to Fourier transform mass 
spectrometry (FT-MS) in the Radboud Proteomics Centre as described previ-
ously (Vogel et al., 2007). In brief, proteins were separated on a conven-
tional 10% SDS-PAGE gel, then the gel was cut into eight slices for digestion 
by trypsin (two slices per lane, one for high molecular weight and one for 
low: S1 and S2 for GST, S3 and S4 for GST-TRPV6 C tail, S5 and S6 for 
GST-TRPM8 N tail, and S7 and S8 for GST-TRPM8 C tail). Peptide identifi-
cation experiments were performed using a nano-HPLC 1100 nanoflow 
system (Agilent Technologies) connected online to a linear quadrupole ion 
trap-Fourier transform mass spectrometer (LTQ-FT; Thermo Fisher Scientific). 
Peptides and proteins were identified using the Mascot (Matrix Science) 
algorithm to search a local version of the NCBInr database (http://www 
.ncbi.nlm.nih.gov). First-ranked peptides were parsed from the Mascot da-
tabase search HTML files with MSQuant (http://msquant.sourceforge.net) 
to generate unique first-ranked peptide lists. The full list of interacting pep-
tides can be found in Table S1 and the summary of the number of inter-
acting peptides in Table S2.
Cell culture and transfection
HEK 293 and lymph node carcinoma of prostate (LNCaP) C4-2 cells (pro-
vided by F. Viana, Instituto de Neurociencias de Alicante, Universidad 
Miguel Hernandez, CSIC, Alicante, Spain; and L.A. Pardo, Max-Planck-
Institute of Experimental Medicine, Göttingen, Germany) were grown in 
DMEM and RPMI 1684 (Invitrogen), respectively, supplemented with 10% 
fetal calf serum (Poly-Labo; Seromed), l-glutamine (5 mM; Sigma-Aldrich), 
and kanamycin (100 mg/ml; Sigma-Aldrich). Human epithelial prostate 
cells, Ep156T, were a gift of V. Rotter (Weizmann Institute of Science, 
Rehovot, Israel) and were grown in MCDB 153 modified by Biological 
Industries as described previously (Kogan et al., 2006).
Cells were transfected with 2 µg of each construct or 50 nM of 
siRNA and 0.2 µg of pmax GFP using either Nucleofector (Amaxa) or Fu-
GENE HD reagent (Roche) and HiPerFect Transfection Reagent (QIAGEN). 
Control experiments were performed by transfecting the empty vector or 
siRNA to Luciferase (siLuc).
Cells were used for patch-clamp experiments 24 h after nucleofec-
tion and for cell surface biotinylation 48 h after transfection.
Immunoprecipitation and immunoblotting
Cells were cotransfected with a his-tagged hTRPM8pcDNA4 plasmid and 
human influenza agglutinin (HA)-tagged TCAF1 or myc-tagged TCAF2, 
washed twice with PBS, and incubated for 60 min on ice in lysis buffer (1% 
The ethics committee of the faculty of medicine and the state medical 
board agreed to these investigations, and informed consent was obtained 
from all patients.
Cloning and siRNA
The coding sequence of the N-terminal tail of TRPM8 (690 aa, S2-K691) 
was amplified from the hTRPM8pcDNA4 plasmid (Thebault et al., 2005) 
and cloned into the pGEX6p-2 vector (tac promoter) for chemically in-
ducible, high-level expression of GST-tagged recombinant proteins (GE 
Healthcare) as a BamHI–XhoI fragment using the primers 5-CGGGAT-
CCTCCTTTCGGGCAGCCAG-3 and 5-CCGCTCGAGTCACTTGGTG-
TCTCGGGAAATC-3. Similarly, the C-terminal tail of TRPM8 (124 aa, 
G980-K1104) was cloned as a BamHI–XhoI fragment into the tac promoter 
pGEX6p-2 vector using the primers 5-CGGGATCCGGCTACACGGT-
GGGCAC-3 and 5-CCGCTCGAGTCACACGAGTTTGATTTTATTAGC-
AATC-3. The TCAF1 and TCAF2 genes were cloned in the pGEM-T Easy 
vector (T7 and SP6 RNA polymerase promoter; Promega) from normal human 
prostate poly(A)+ RNA (Takara Bio Inc.) using the following primers: for 
TCAF1, 5-ATGGCGACTCCCTCTGCTGC-3 and 5-TCAGTGGGGCA-
TCTGTGTGAGG-3; for TCAF2, 5-ATGGCGACCATTGCTGCTGC-3 and 
5-TCATCCCCTTCTCCCAGAATTTCTGC-3. TCAF1 and TCAF2 were both 
subcloned as EcoRI fragments into the pCMV-TnT vector (CMV promotor; 
Promega), TCAF1 as a XhoI fragment in the pCMV-HA vector (CMV promo-
tor; Takara Bio Inc.), and TCAF2 as an EcoRI fragment in the pCMV-myc 
vector (CMV promotor; Takara Bio Inc.).
For the TCAF1PI3K mutant, a stop codon was introduced into the 
pCMV-TNT-TCAF1 construct by the substitution C2162G using in vitro 
mutagenesis (QuikChange Site-directed Mutagenesis kit; Agilent Tech-
nologies). All long PCRs were performed with the High Fidelity Phusion 
DNA Polymerase (Finnzymes) and all constructs were verified by se-
quence analysis.
For the fluorescent chimera, mTurquoise2 and SYFP2 were cloned in 
a home-made vector derived from pEGFP-N1 (CMV promotor; Takara Bio 
Inc.) in which we substituted the multicloning site with a homemade coun-
terpart that accept 5 cloning of DNA with NheI and AgeI and 3 cloning 
of DNA with Sac II and Not I. The sense linker sequence was: 
5-GCTAGCATTGAACCGGTGGAGTAGGCgCCGGtGGAGGAGGAGG-
GTtACCTGTTGTTGGAGGAGTTGTTGGAGGAGGAGTTGTTGGT-
GGTGTTGTTGGTGTTGGGTtACCTGGTGGCgCCGGtGGTGTTGGCCG-
CGGATTATGCGGCCGC-3. This vector was design to normalize the size 
and amino acid sequence of the linker between the protein of interest and 
the fluorescent protein. Labels given to these vectors are intuitive: X-pSYFP2-
N means that SYFP2 consists of the N terminal part of the chimera while 
X-pmTurquoise2-C means that mTurquoise2 is located at the C terminus of 
the chimera. TRPM8-pmTurquoise2-C, TCAF1-pSYFP2-N, TCAF1-pSYFP2-C, 
TCAF2-pSYFP2-N, and TCAF2-pSYFP2-C were constructed as described. 
T.W.J. Gadella (Swammerdam Institute for Life Sciences, van Leeuwenhoek 
Centre for Advanced Microscopy, University of Amsterdam, Amsterdam, 
Netherlands) provided the riginal pmTurquoise2-N1, pmTurquoise2-C1, 
and pSYFP2-C1 vectors. Before the clone of TCAF1 and -2 in the recipient 
vector, the AgeI site was suppressed by single point mutation using in vitro 
mutagenesis (QuikChange Site-directed Mutagenesis kit) and checked by 
sequencing. Fragments were amplified by the mean of PCR with the follow-
ing couples of primers: for TRPM8, 5-GATCCCGCGGTTCCTTTCGGG-
CAGCCAGG-3/5-AGTCGCGGCCGCTCAATGGTGATGGTGATGATG-
ACCGG-3; for TCAF1, 5-GATCGCTAGCCGCCACCATGGCGACTC-
CCTCTGCTG-3/5-GATCACCGGTGTGGGGCATCTGTGTGA-3 and 
5-GATCCCGCGGTGCGACTCCCTCTGCTGC-3/5-AGTCGCGGCCG-
CTCAGTGGGGCATCTGTGTGAGGA-3; for TCAF2, 5-GATCGCTAGC-
CGCCACCATGGCGACCATTGCTGC-3/5-GATCACCGGTTCCCCTT-
CTCCCAGAATTTCT-3 and 5-GATCCCGCGGTGCGACCATTGCTGCT-
GCT-3/5-AGTCGCGGCCGCTCATCCCCTTCTCCCAGAATTTCTGC-3. 
After a 0.8%-agarose gel purification (Wizard SV gel and PCR Clean-Up 
System; Promega), PCR products and recipient vectors were digested with 
either NheI + AgeI or SacII + NotI at 37°C overnight. After DNA purifica-
tion, PCR products and vectors were ligated overnight and transformed in 
DH5 chemo-competent bacteria (NEB). Final plasmids were extracted 
and sequenced before performing the experiments.
siRNAs were generated against the human sequences 5-TTATTG-
GAGAGGCTTCATT-3 (siTCAF1; Eurogentec), 5-GGCTTCCCTGGTAACA-
TCATCCTCA-3 (siTCAF2; Invitrogen), and the luciferase 5-CTTACGCT-
GAGTACTTCGA-3 (siLuc; Eurogentec).
GST fusion proteins and pull-down assay
TRPM8 N- and C-terminal tail GST fusion proteins were produced and 
purified as per the manufacturer’s instructions. In brief, BL-21 cells were 
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Immunocytochemistry
Cells were cotransfected with his-tagged hTRPM8pcDNA4 plasmid and 
HA-tagged TCAF1 or myc-tagged TCAF2, and were washed two times, 
fixed with 4% formaldehyde–1× PBS for 15 min, washed three times, then 
permeabilized in PBS-gelatin (1.2%) complemented with 0.01% Tween 20 
and 100 mM glycine for 30 min at 37°C. Afterward, cells were incubated 
with primary antibodies: 1:200 goat polyclonal anti-TRPM8 antibody (Anti-
bodies Online), rabbit anti-HA (1:100; Abcam), and mouse anti-myc 
(1:100; Invitrogen) in PBS-gelatin at 37°C for 1.5 h. After thorough washes, 
the slides were treated with the corresponding secondary antibodies: donkey 
Rhodamine Red-X–labeled anti–goat (dilution 1:300; Jackson Immuno-
Research Laboratories, Inc.) and donkey Alexa Fluor 488–labeled anti–rabbit 
(dilution 1/250; Jackson ImmunoResearch Laboratories, Inc.) diluted in 
PBS-gelatin for 1 h at room temperature. The slides were then incubated 
with 0.3% Sudan Black in 70% ethanol in order to reduce autofluorescence, 
washed two times, and mounted with Mowiol. Fluorescence analysis was 
performed using a confocal microscope (LSM 700; Carl Zeiss, Inc.) and 
ImageJ analysis software.
Total RNA extraction and reverse transcription
Total RNAs were extracted from small pieces of localized tumor using 
the RNeasy Midi kit (QIAGEN) and from bone marrow aspirates using 
the QIAamp RNA Blood kit (QIAGEN) according to the manufacturer’s 
instructions.
Total RNA from human testis, dorsal root ganglion, prostate, blad-
der, colon, kidney, liver, lung, smooth muscle, heart, and brain was pur-
chased from Takara Bio Inc., and subjected to reverse transcription as 
described in Bidaux et al. (2007).
Electrophysiology
Macroscopic membrane ion currents were recorded at 37°C using the 
patch-clamp technique in its whole cell configuration. The currents were 
acquired using a PC-9 amplifier (HEKA) in the case of whole-cell measure-
ments and an Axopatch 200B amplifier (Molecular Devices), and analyzed 
offline using pClamp (Molecular Devices) and Origin software (OriginLab 
Corporation). The extracellular solution (osmolarity 310 mOsmol/liter) 
contained (in mM): 150 NaCl, 5 KCl, 10 TEA-Cl, 10 Hepes, 10 glucose, 
1 MgCl2, and 2 CaCl2, pH 7.3 (adjusted with NaOH). The intracellular 
pipette solution (osmolarity 290 mOsmol/liter) contained (in mM): 140 
CsCl, 10 Hepes, 8 EGTA, 1 MgCl2, and 4 CaCl2 (100 nM free Ca2+), 
pH 7.2 (adjusted with CsOH). Patch pipettes were made from borosili-
cate glass capillaries (WPI). The resistance of the pipettes varied between 
3 and 5 MΩ. For single-channel analysis, the extracellular and pipette 
solutions contained (in mM): 150 KCl, 5 glucose, 10 Hepes, 1 CaCl2, and 
2 MgCl2, pH 7.3 (adjusted with KOH) to bring the membrane potential 
close to zero and minimize junction potentials. Necessary supplements 
were added directly to the respective solutions at concentrations that would 
not significantly change the osmolarity. Changes in the external solutions 
were performed using a multibarrel puffing micropipette with common out-
flow that was positioned in close proximity to the cell under investigation. 
During the experiment, the cell was continuously superfused with the solu-
tion via a puffing pipette to reduce possible artifacts related to the switch 
from static to moving solution and vice versa.
To achieve the expression of the TRPM8 channel with a plasma 
membrane density of one channel per patch on average, HEK-293M8i cells 
were induced by 1 µg/ml tetracycline until the first open TRPM8 channels 
could be detected (typically 4 h, 20 min). To prevent the overexpression of 
the TRPM8 channel and avoid the appearance of multiple channels, the 
currents were recorded within 30 min of observation of the initial TRPM8 
activity. Alternatively, HEK-293M8i cells were treated with 1 µg/ml tetracy-
cline for a short duration (typically 20 min). After this, cells were washed 
multiple times with fresh media and left overnight. Both approaches yielded 
identical TRPM8 currents.
The acquisition of TRPM8 activity was performed in cell-attached 
patches at room temperature (T = 20°C, controlled by a room thermostat). 
First, patches were subjected to a series of potentials ranging from 100 mV 
to 150 mV to assess the presence of the TRPM8 channel. Patches that con-
tained TRPM8 activity were then recorded using an episodic stimulation 
protocol that held membrane potential at 100 mV for 10 s followed by the 
application of 30 mV for 2 s to prevent TRPM8 activity rundown. First, 
activity at room temperature was recorded, followed by the application of 
100 µM menthol, to maximally stimulate TRPM8 channel.
Selection of traces suitable for single-channel analysis was per-
formed by rejecting traces that at any point exhibited multiple simultane-
ous openings. Observing menthol-stimulated activity for at least 5 min 
Triton X-100, 1% sodium deoxycholate, 150 mM NaCl, 10 mM NaKPO4, 
pH 7.2, and anti-protease cocktail; Sigma-Aldrich). After centrifugation 
(12,000 g for 10 min at 4°C) of the lysates, protein concentration was de-
termined by the BCA assay (Thermo Fisher Scientific), and equal amount of 
supernatants were incubated overnight at 4°C with mouse anti-his anti-
body (Invitrogen) immobilized on protein A/G PLUS agarose beads (Santa 
Cruz Biotechnology, Inc.). The pellet was washed three times, resuspended 
in SDS sample buffer, and heated at 37°C for 30 min, separated on 10% 
wt/vol SDS-PAGE gels, and analyzed by immunoblotting using rabbit anti-
HA (1:2,000; Abcam), mouse anti-myc (1:500; Invitrogen), mouse anti-actin 
(1:5,000; Sigma-Aldrich), mouse anti-calnexin (1:2,000; EMD Millipore), 
rabbit anti-TRPM8 (1:1,500; Alomone Labs Ltd), and rabbit anti-TRPV6 
(1:200; Santa-Cruz Biotechnology, Inc.) antibodies.
Biotinylation
Cells were washed twice with ice-cold PBS containing 1 mM MgCl2 and 
0.5 mM CaCl2 (PBS-CM) 48 h after transfection, and surface biotinylation 
was performed by incubating the cells twice for 20 min at 4°C with 1 mg/ml 
EZ-Link Sulfo-NHS-LC-LC-Biotin (Pierce). Subsequently, cells were incubated 
for 5 min with quenching solution (50 mM NH4Cl in PBS-CM) at 4°C and 
rinsed twice with cold PBS-CM. Cells were lysed with 1 ml of lysis buffer 
(1% Triton X-100, 1% sodium deoxycholate, 150 mM NaCl, 10 mM NaKPO4, 
pH 7.2, and anti-protease cocktail; Sigma-Aldrich) for 1 h on ice. Lysates 
were added to 50 µl NeutrAvidin-agarose beads (Thermo Fisher Scien-
tific). After incubation for 16 h at 4°C, the beads were washed twice with 
PBS-CM, twice with lysis buffer, and once with 10 mM Tris-HCl, pH 7.5. Fi-
nally, biotinylated proteins were eluted with SDS-PAGE loading buffer, sep-
arated on 10% wt/vol SDS-PAGE gel, and analyzed by immunoblotting as 
described for the immunoprecipitation assays with rabbit anti-TRPM8 an-
tibody (1:1,500; Alomone Labs Ltd).
TD FLIM
TD FLIM is one of the best methods to measure FRET occurrence with a 
good spatial resolution and independent of the concentration of proteins 
(Sipieter et al., 2013). As the C termini of tetrameric TRPM8 are gathered 
in a restricted volume, we have chosen to fuse the recently developed cyan 
variant (Goedhart et al., 2012), mTurquoise2, at the C terminus of TRPM8. 
To optimize FRET occurrence, and because both the orientation and steric 
effect of TCAF were unknown, we generated both N-terminal and C-terminal 
SYFP2 fusion to TCAFs. Because, our preliminary experiment reported 
a better FRET efficiency between TRPM8-mTurquoise2 and SYFP2 fused 
at the N terminus of both TCAFs, we then focused on these pairs of FRET. 
For live-cell imaging, 120,000 HEK293 cells were placed on 35-mm glass- 
bottom dishes (MatTek Corporation) and transfected for 1 d. Before perform-
ing the experiment, dishes were filled with L-15 medium without phenol red 
(Life Technologies), and kept at 37°C using a stage incubator (Life Imaging 
Services). FLIM was performed with a confocal head (TCS SP5 X; Leica) 
with the SMD upgrade, mounted on an inverted microscope (DMI6000; 
Leica). A pulsed diode laser, PDL 800-B (PicoQuant GMBH), delivered 
40 MHz repetitive rate pulses at 405 nm. The confocal pinhole was set to 
1 Airy for a 0.921-µm optical slice. Single-photon events originated from the 
illuminated voxel were collected through a 63×/1.2 NA water-immersion 
objective lens and recorded with a TCSPC detector (HydraHarp 400; Pico-
Quant GMBH). Fluorescence was detected through a 483/32 single 
band-pass filter (Semrock) on Single Photon Avalanche Photodiodes, SPAD 
(MPD), set up at 256 × 256 pixels. Arrival time of single photons was 
measured with SymPhoTime software (PicoQuant GMBH) while the images 
were taken with LAS AF software (Leica). To obtain the best resolution, a 
fivefold zoom factor was applied, giving a pixel size of 0.193 µm and an 
image size of 49.21 × 49.21 µm. Because the statistical determination 
of the distribution of single photon arrival time requires a minimum of 100 
photons per pixel, 120 frames were acquired at 200 Hz and summed in 
the final image.
Because interaction dynamics rely on both the Kd of the interaction 
and the spatial and temporal concomitance of the two proteins, measuring 
the interaction between a membrane-incorporated protein and a cytosol-
diffusing protein is convoluted by strong divergence between their diffusion 
coefficients and their volume of mobility. Therefore, to test the ability of a 
free-diffusing protein to interact with TRPM8 for a period sufficient to gener-
ate a FRET signal, we concomitantly expressed a free SYFP2 protein with 
TRPM8-mTurquoise2.
The TD FLIM images have been analyzed with custom-made soft-
ware named MAPI (IRI, USR 3078 Centre National de la Recherche Scien-
tifique, BCF).
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Fig. S3 shows that menthol-induced responses in human prostate epithelial 
cells are modulated by TCAF1 and TCAF2. Fig. S4 shows a sample activity 
of the TRPM8 channel. Fig. S5 depicts a comparison of the fit of control 
and TCAF1-bound TRPM8 activity to different kinetic models. Table S1 
shows the full list of interacting peptides with TRPM8 channel, a summary 
of which can be found in Table S2. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201402076/DC1.
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and taking mean open and closed dwell times to be 0.6 and 19 ms, 
respectively, the probability that two identical channels would never exhibit 
multiple conductance levels was <10210 (Baumgartner et al., 1997), 
which demonstrates the validity of this rejection criterion. Recorded activ-
ity was quantified by performing a single-channel search analysis using 
the Clampfit-10 program (pClamp software suit, Molecular Devices) and 
QuB 2.0 programs as described previously (Qin and Li, 2004; Fernández 
et al., 2011).
Imaging
Cytosolic Ca2+ concentrations were measured using the ratiometric dye 
Fura-2/AM (Invitrogen Ltd, UK) and quantified according to Grynkiewicz 
et al. (1985). Cells were loaded with 1 µM of Fura-2/AM for 30 min 
then washed and bathed in the same extracellular solution as described 
for whole cell recording for at least 10 min before Ca2+ measurements 
were done. Observations were performed at 37°C on an Eclipse Ti micro-
scope using an S Fluor 20×/0.75 NA objective lens (both from Nikon). 
Images were collected through a Rolera EM-C2 charge-coupled device 
(CCD) camera (QImaging) controlled with Metafluor software (Molecular 
Devices). Data were then analyzed with Origin 6.1 software (OriginLab 
Corporation). Unless otherwise indicated, all reagents were purchased 
from Sigma-Aldrich.
For the confocal Ca2+ imaging, changes in the [Ca2+]i in LNCaP cells 
were imaged using the high-affinity fluorescent Ca2+ indicator fluo-4, which 
was loaded by a 50-min incubation of the cells with 5 µM fluo-4 acetoxy-
methyl ester followed by a 60-min wash to allow time for de-esterification. 
Confocal [Ca2+]i imaging was performed as described previously (Povstyan 
et al., 2011; Shapovalov et al., 2013a). In brief, experimental chambers 
containing the cells were placed on the stage of an Axiovert 200M in-
verted microscope attached to an LSM 510 META laser-scanning unit (Carl 
Zeiss). x-y confocal images of fluo-4 fluorescence were acquired at 0.6 Hz 
using a Plan-Apochromat 40× 1.3 NA objective lens (Carl Zeiss). Fluo-4 
fluorescence was excited by the 488 nm line of a 500 mW argon ion laser 
(Laser-Fertigung) and was captured at wavelengths >505 nm. The illumina-
tion intensity was attenuated to 0.6% with an acousto-optical tunable filter 
(Carl Zeiss). In all experiments, the photomultiplier gain was set at 688. To 
optimize signal quality, the pinhole was set to provide a confocal optical 
section <4 µm.
Time-lapse video microscopy
Cells were seeded at low density and kept at 37°C under 5% CO2 in an 
incubator chamber for time-lapse video recording (Okolab). Cell move-
ments were monitored with an inverted microscope (Eclipse Ti-E; Nikon) 
using a 10×/0.25 NA Plan objective lens.
Images were acquired every 10 min for a time lapse of 10 h with a 
CCD video camera (Roper Scientific) using MetaMorph software (Univer-
sal Imaging Corp.). Image stacks were analyzed with ImageJ software and 
at least 60 cells per condition were manually tracked using the MtrackJ plu-
gin. We excluded dividing cells as well as cells that exited the imaged field 
during the time-lapse acquisition period. The parameters of speed and 
migratory persistence index were considered for the data analyses. The 
migratory persistence index was calculated as the Euclidean distance from 
the starting point to the final position of the cell (i.e., the shortest distance 
distance) divided by the accumulated distance (total path length). This 
value was then normalized for the total duration of the cell track duration 
and the value was multiplied by the square root of the cell track duration 
as described previously (Messina et al., 2011).
At least six fields for each condition were analyzed in each indepen-
dent experiment. At least three independent experiments were done for 
each experimental condition.
Statistical analysis
Values are expressed as means ± SEM. The statistical significance of differ-
ences between groups was determined by analysis of variance (ANOVA) 
followed by pairwise comparison using Scheffe’s method for patch-clamp 
recordings and an unpaired Student’s t test for qPCR. A nonparametric un-
paired Wilcoxon-Mann-Whitney test was used as a scoring method to as-
sess statistical significance for migration assays. Differences in means with 
a P < 0.05 were considered statistically significant. Statistical analyses were 
performed using Origin 6.1 software (OriginLab Corporation) and InStat 
v3.06 (GraphPad Software, Inc.) or Kaleidagraph software for migration 
assays (Synergy Software).
Online supplemental material
Fig. S1 shows TCAF interactions with TRPV6 and TRPM2. Fig. S2 shows 
the expression and functional analysis of the TRPM8–TCAFs complex. 
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